To the full analysis
Ambuja Cements stock: growth
AMBUJACEM.NSAmbuja Cements reported $4.3B in revenue for fiscal 2026, up 21.2% on the prior year, up 10.9% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Revenue (Annual rate)
10.2%
per year from 2007 to 2026, per share 7.4%
Earnings (Annual rate)
5.6%
per year from 2007 to 2026, per share 2.9%
Free cash flow (Annual rate)
no data
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2021 | since 2016 | since 2007 | |
|---|---|---|---|
| Revenue | 10.9% | 15.8% | 10.2% |
| Revenue per share | 6.2% | 13.3% | 7.4% |
| Earnings | 14.9% | 19.3% | 5.6% |
| Earnings per share | 10.0% | 13.9% | 2.9% |
| Free cash flow | no data | no data | no data |
| Free cash flow per share | no data | no data | no data |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2007 | $679.52M | $179.59M | $105.53M |
| 2008 | $607.82M | $196.22M | $79.7M |
| 2009 | $664.03M | $147.71M | −$71.68M |
| 2010 | $752.19M | $129.34M | $83.07M |
| 2011 | $785.49M | $134.24M | $108.74M |
| 2012 | $893.3M | $130.49M | $93.88M |
| 2013 | $1.02B | $137.45M | $123.4M |
| 2014 | $962.09M | $135.9M | $49.11M |
| 2015 | $1.05B | $158M | $90.44M |
| 2016 | $989.99M | $85.87M | $99.15M |
| 2017 | $2.11B | $117.46M | $202.01M |
| 2018 | $2.45B | $161.17M | $247.46M |
| 2019 | $2.7B | $231.43M | $65.75M |
| 2020 | $2.88B | $222.67M | $326.44M |
| 2021 | $2.56B | $251.42M | $329.36M |
| 2022 | $3.03B | $295.52M | $316.21M |
| 2023 | $3.29B | $206.04M | −$297.34M |
| 2024 | $3.46B | $379.81M | $208.21M |
| 2025 | $3.55B | $442.95M | −$685.53M |
| 2026 | $4.3B | $502.55M | −$85.26M |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2026, period end 31 Mar 2026
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = ₹94.0836)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Weak, published since 7 Nov 2026 (in the score history since 2 Oct 2026)
- Valuation signal Overvalued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.